On the other hand, the inhibition of JNK pathway repressed the c-Jun phosphorylation and NOX4 expression, followed by the inhibition of ROS production, MMP-1 and MMP-9 expression, and invasion ability in OA-treated cancer cells (Figure S12). Here, JUN is linked to cancer.